Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 0.453 USD -3.51% Market Closed
Market Cap: 20m USD

Intrinsic Value

The intrinsic value of one HBIO stock under the Base Case scenario is 2.358 USD. Compared to the current market price of 0.453 USD, Harvard Bioscience Inc is Undervalued by 81%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HBIO Intrinsic Value
2.358 USD
Undervaluation 81%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare HBIO to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HBIO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Harvard Bioscience Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Harvard Bioscience Inc

Current Assets 44.9m
Cash & Short-Term Investments 5.5m
Receivables 13.5m
Other Current Assets 25.9m
Non-Current Assets 34.9m
PP&E 12.3m
Intangibles 19.1m
Other Non-Current Assets 3.5m
Efficiency

Free Cash Flow Analysis
Harvard Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Harvard Bioscience Inc

Revenue
91.4m USD
Cost of Revenue
-39.2m USD
Gross Profit
52.2m USD
Operating Expenses
-56.9m USD
Operating Income
-4.8m USD
Other Expenses
-53.3m USD
Net Income
-58.1m USD
Fundamental Scores

HBIO Profitability Score
Profitability Due Diligence

Harvard Bioscience Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining Operating Margin
28/100
Profitability
Score

Harvard Bioscience Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

HBIO Solvency Score
Solvency Due Diligence

Harvard Bioscience Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
35/100
Solvency
Score

Harvard Bioscience Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HBIO Price Targets Summary
Harvard Bioscience Inc

Wall Street analysts forecast HBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HBIO is 3.06 USD with a low forecast of 3.03 USD and a high forecast of 3.15 USD.

Lowest
Price Target
3.03 USD
569% Upside
Average
Price Target
3.06 USD
575% Upside
Highest
Price Target
3.15 USD
595% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Harvard Bioscience Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HBIO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one HBIO stock?

The intrinsic value of one HBIO stock under the Base Case scenario is 2.358 USD.

Is HBIO stock undervalued or overvalued?

Compared to the current market price of 0.453 USD, Harvard Bioscience Inc is Undervalued by 81%.

Back to Top